About Krystal Connect
ABOUT KRYSTAL CONNECT
Krystal Connect is a personalized support program
Whether you are thinking about treatment, are ready to start, or just want more information about DEB, Krystal Connect is here for you.
When you enroll in Krystal Connect, you will be connected to a dedicated team, including your Patient Access Liaison (PAL), Clinical Nurse Educator, and Care Coordinator.* Your team is available to:
Provide disease education and resources on DEB
Share webinars, emails, and programs that include real-world experience from those on VYJUVEK
Connect you to additional resources for the DEB community through advocacy groups assistance options
Support in reducing out-of-pocket costs or finding assistance options. Eligible patients may pay as little as $0 for VYJUVEK
Provide a temporary supply of medication at no cost to eligible patients prescribed VYJUVEK while the insurance approval is in process through the VYJUVEK Quick Start Program
Help you navigate the insurance process
Prepare you to get started on VYJUVEK. Your PAL will make sure you have all the information you need and know what to expect
Provide information to help you locate a treating doctor in your area
Provide education and personalized support on cleansing, ointments, and hydrophobic dressings
*Krystal's team does not direct patient care or provide medical advice.
Call Krystal Connect at 1-844-5-KRYSTAL
GETTING STARTED
If you and your doctor decide that VYJUVEK is an option for you, you will follow these steps:
1. Enrollment:
Your doctor will complete the VYJUVEK Enrollment Form. This will serve as your prescription and allows Krystal Connect to begin working with you. You need to complete Steps 1 and 2 outlined in purple on the Enrollment Form. We can text or email you the form after your doctor submits your prescription.
Download the Enrollment Form
2. Welcome call:
Once Krystal Connect receives your enrollment form, your PAL will reach out to welcome you, to learn more about your needs, and explain how they can help.
Look for “Krystal Connect” on your caller ID.
3. Helping evaluate your coverage options:
Your PAL will help with benefits investigation to better understand your insurance coverage and next steps. If you are eligible, your PAL may share information and resources about additional financial assistance options, including:
- $0 Copay Program can help reduce out-of-pocket costs to as low as $0*
- For those without insurance coverage or who may have insurance but don’t have VYJUVEK coverage, our Patient Assistance Program (PAP) may be able to provide VYJUVEK at no costâ€
- Provide a temporary supply of medication at no cost if you are prescribed VYJUVEK while the insurance approval is in process through the VYJUVEK Quick Start Program
4. Preparing for Application:
The Krystal Connect team will make sure you receive all the information you need to get ready to start applying VYJUVEK, including personalized training on at-home VYJUVEK application.
5. Ongoing support:
The Krystal Connect team will check in to see how you’re doing, answer any questions you may have, and support you throughout your VYJUVEK treatment.
*Patient Eligibility & Terms and Conditions: The VYJUVEK Copay Program is available only to commercially insured patients with a valid prescription for VYJUVEK. Patients must be US citizens or residents for at least six months. Patients or their guardian must be 18 years of age or older to enroll in the program. Patients are not eligible for copay assistance through the VYJUVEK Copay Program if they are cash-paying patients, or enrolled in any state or federally funded programs for which drug prescriptions or coverage could be paid in part or in full, including, but not limited to, Medicare Part B, Medicare Part D, Medicaid, Medigap, VA, DoD, or TRICARE (collectively, “Government Programs”), or where prohibited by law. This offer is not health insurance. The VYJUVEK Copay Program applies only to out of pocket costs associated with VYJUVEK and not the cost of related medical services. In any calendar year commencing January 1, the maximum copay benefit amount paid by Krystal Biotech, Inc. will be $15,000. Eligible patients may pay as little as $0 per prescription, up to the annual maximum copay assistance amount of $15,000. Additional terms and conditions apply. See www.krystalconnect.com/pdf/us_terms.pdf for full terms and conditions.
†The VYJUVEK Patient Assistance Program (PAP) is designed to provide VYJUVEK at no cost to eligible patients who meet certain financial need and insurance coverage eligibility criteria. Patients may be eligible to receive free drug if they demonstrate qualifying financial need, are uninsured or functionally uninsured, are US citizens or residents for at least six months, and have a valid prescription for VYJUVEK as supported by information provided in the program application. Eligibility does not guarantee approval for participation In the program. The PAP does not cover the cost of previously purchased product or medical services. See www.krystalconnect.com/pdf/us_terms.pdf for full terms and conditions.
INDICATION AND USAGE
VYJUVEK is a topical gel used to treat wounds in adult and pediatric patients (from birth) with dystrophic epidermolysis bullosa (DEB).
IMPORTANT SAFETY INFORMATION
VYJUVEK gel should be applied by a healthcare professional, patient, or caregiver.
After treatment, patients and caregivers should be careful not to touch treated wounds and dressings until the next bandage change. If accidentally exposed to the VYJUVEK gel, clean the affected area.
Wash hands and wear protective gloves when changing wound dressings. Disinfect bandages from the first dressing change with a virucidal agent and dispose of the disinfected bandages in a separate sealed plastic bag in household waste. Dispose of the subsequent used dressings in a sealed plastic bag in household waste.
The most common adverse reactions (>5%) were itching, chills, redness, rash, cough, and runny nose. These are not all the possible side effects with VYJUVEK. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or to the Sponsor at 1-844-557-9782.
Please see Important Safety Information above and click here for full Prescribing Information.
IMPORTANT SAFETY INFORMATION
INDICATION AND USAGE
VYJUVEK is a topical gel used to treat wounds in adult and pediatric patients (from birth) with dystrophic epidermolysis bullosa (DEB).
IMPORTANT SAFETY INFORMATION
VYJUVEK gel should be applied by a healthcare professional, patient, or caregiver.
After treatment, patients and caregivers should be careful not to touch treated wounds and dressings until the next bandage change. If accidentally exposed to the VYJUVEK gel, clean the affected area.
Wash hands and wear protective gloves when changing wound dressings. Disinfect bandages from the first dressing change with a virucidal agent and dispose of the disinfected bandages in a separate sealed plastic bag in household waste. Dispose of the subsequent used dressings in a sealed plastic bag in household waste.
The most common adverse reactions (>5%) were itching, chills, redness, rash, cough, and runny nose. These are not all the possible side effects with VYJUVEK. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or to the Sponsor at 1-844-557-9782.
Please see Important Safety Information above and click here for full Prescribing Information.
×
You are about to leave the VYJUVEK.com website
Are you sure you want to leave?